Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
BARK
BARK
$94.9M
| $250K | ﹤0.01% |
9,001
-2,636
| -23% | -$92.2K |
|
|
ACRE
3827
Ares Commercial Real Estate
ACRE
$262M
| $249K | ﹤0.01% |
53,680
-26,697
| -33% | -$141K |
|
3828
Puma Biotechnology
PBYI
$461M
| $246K | ﹤0.01% |
83,261
-5,146
| -6% | -$16.1K |
|
3829
Ponce Financial Group
PDLB
$502M
| $246K | ﹤0.01% |
19,447
-9,638
| -33% | -$126K |
|
|
OLPX
3830
DELISTED
Olaplex Holdings
OLPX
| $245K | ﹤0.01% |
192,916
-69,397
| -26% | -$103K |
|
3831
VanEck BDC Income ETF
BIZD
$1.7B
| $245K | ﹤0.01% |
+14,594
| New | +$249K |
|
3832
GrafTech
EAF
$206M
| $244K | ﹤0.01% |
27,960
-12,883
| -32% | -$167K |
|
3833
Dynagas LNG Partners
DLNG
$136M
| $244K | ﹤0.01% |
64,800
| – | – |
|
3834
Gevo
GEVO
$398M
| $244K | ﹤0.01% |
210,400
-8,731
| -4% | -$14.6K |
|
3835
Denison Mines
DNN
$2.97B
| $243K | ﹤0.01% |
187,112
-1,663
| -0.9% | -$2.78K |
|
3836
iHeartMedia
IHRT
$461M
| $243K | ﹤0.01% |
147,199
-113,794
| -44% | -$229K |
|
|
TECX
3837
Tectonic Therapeutic
TECX
$685M
| $243K | ﹤0.01% |
13,710
-2,264
| -14% | -$73.8K |
|
|
CIO
3838
DELISTED
City Office REIT
CIO
| $243K | ﹤0.01% |
46,729
-19,441
| -29% | -$99.8K |
|
|
EFXT
3839
Enerflex
EFXT
$2.63B
| $241K | ﹤0.01% |
31,232
-249
| -0.8% | -$2.2K |
|
3840
Primis Financial Corp
FRST
$417M
| $241K | ﹤0.01% |
24,651
-8,135
| -25% | -$86.8K |
|
3841
Aquestive Therapeutics
AQST
$543M
| $241K | ﹤0.01% |
82,957
-35,754
| -30% | -$108K |
|
3842
Descartes Systems
DSGX
$6.34B
| $240K | ﹤0.01% |
2,385
+765
| +47% | +$84.6K |
|
3843
Ultrapar
UGP
$6.38B
| $240K | ﹤0.01% |
77,833
+32,700
| +72% | +$93.7K |
|
3844
Red River Bancshares
RRBI
$683M
| $239K | ﹤0.01% |
4,618
-2,287
| -33% | -$124K |
|
|
EH
3845
EHang Holdings
EH
$433M
| $238K | ﹤0.01% |
11,400
+10,007
| +718% | +$203K |
|
3846
ROBO Global Robotics & Automation Index ETF
ROBO
$2.12B
| $238K | ﹤0.01% |
4,612
| – | – |
|
3847
Fulcrum Therapeutics
FULC
$280M
| $237K | ﹤0.01% |
82,457
-39,613
| -32% | -$146K |
|
3848
Eledon Pharmaceuticals
ELDN
$293M
| $237K | ﹤0.01% |
70,000
| – | – |
|
3849
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $237K | ﹤0.01% |
3,668
| – | – |
|
3850
Concrete Pumping Holdings
BBCP
$483M
| $237K | ﹤0.01% |
43,406
-12,695
| -23% | -$88.3K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.